My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Hikal announces successful USFDA insepction of its API and Intermediates manufacturing facility
Jan 10,2017

Hikal announced that the Companys API and Intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the US FDA in compliance with their requirements. At the end of the successful inspection, the Company have been informed by the Investigator that n++zeron++ 483 observations were issued. This was a routine inspection by the US FDA.

Powered by Capital Market - Live News

Grasim Industries allots 4,460 equity shares
Jan 10,2017

Grasim Industries announced that the Stakeholders Relationship Committee of the Board of Directors of the Company has approved allotment of 4,460 Equity shares of Rs. 2 each of the Company upon exercise of stock options and restricted stock units under the Companys Employee Stock Option Scheme, 2006 and Employee Stock Option Scheme, 2013.

These shares shall rank pari passu with the existing equity shares of the Company in all respects and shall be subject to the provisions of the Memorandum and Articles of Association of the Company.

Consequent to the above allotment, the equity share capital of the Company stands increased to 46,68,01,520 equity shares of Rs. 2 each aggregating to Rs. 93,36,03,040.

Powered by Capital Market - Live News

Andhra Bank announces change in CFO
Jan 10,2017

Andhra Bank announced that K Rayar, General Manager is designated as the Chief Financial Officer of the Bank with effect from 09 January 2017 in place of Y Amarnath, General Manager.

Powered by Capital Market - Live News

Speedage Commercials announces change in company secretary and compliance officer
Jan 10,2017

Speedage Commercials announced that Nikhil Hule has tendered his resignation from the post of Company Secretary cum Compliance Officer of Company vide his resignation letter dated 09 January 2017; which has been accepted w.e.f. 09 January 2017; hence he stands ceased as Company Secretary cum Compliance Officer of Company on the close of working hours on 09 January 2017.

Further, Dilip Kumar Swarnkar has been appointed in his place as Company Secretary cum Compliance Officer of Company w.e.f. 10 January 2017.

Powered by Capital Market - Live News

Board of Bharat Electronics to consider sub-division of shares
Jan 10,2017

Bharat Electronics announced that at the Board of Directors meeting scheduled on 27 January 2017, the proposal for Sub-division of equity shares of the company of face value of Rs. 10/- each will be consider by the Board.

The aforesaid proposal, if approved by the Board, will be subject to the approval of the Shareholders

Powered by Capital Market - Live News

ISGEC Heavy Engineering fixes record date for interim dividend
Jan 10,2017

ISGEC Heavy Engineering has fixed 20 January 2017 as the Record Date for the purpose of Payment of Interim Dividend.

Powered by Capital Market - Live News

ISGEC Heavy Engineering to pay interim dividend
Jan 10,2017

ISGEC Heavy Engineering announced that interim dividend of Rs 15 per share shall be paid on or before 25 January 2017.

Powered by Capital Market - Live News

Hikal gallops as USFDA issues zero observations after inspection of Jigani plant
Jan 10,2017

The announcement was made during market hours today, 10 January 2017.

Meanwhile, the S&P BSE Sensex was up 173.01 points, or 0.65%, to 26,899.56

On the BSE, 2.01 lakh shares were traded in the counter so far, compared with an average volume of 13,030 shares in the past one quarter. The stock had hit a high of Rs 256.10 and a low of Rs 217.60 so far during the day.

The stock hit a record high of Rs 241.30 on 3 November 2016. The stock hit a 52-week low of Rs 116.60 on 31 March 2016. The stock had underperformed the market over the past 30 days till 9 January 2017, falling 3.67% compared with Sensexs 0.08% fall. The scrip had, however, outperformed the market in past one quarter, gaining 1.85% as against Sensexs 4.83% decline.

The small-cap company has an equity capital of Rs 16.44 crore. Face value per share is Rs 2.

Hikal said that the companys API and intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the US Food and Drug Administration (US FDA) in compliance with their requirements. At the end of the successful inspection, the company have been informed by the investigator that zero 483 observations were issued. This was a routine inspection by the US FDA.

Hikals net profit jumped 216.2% to Rs 15.24 crore on 13.9% rise in net sales to Rs 232.31 crore in Q2 September 2016 over Q2 September 2015.

Hikal is engaged in research and development (R&D), manufacturing and marketing of fine chemicals for the pharmaceutical and agrochemical industries.

Powered by Capital Market - Live News

Board of ISGEC Heavy Engineering declares interim dividend
Jan 10,2017

ISGEC Heavy Engineering announced that the Board of Directors in its meeting held on 10 January 2017, has declared Interim Dividend of Rs. 15/- per equity share of Rs. 10/- each.

Interim Dividend shall be paid on or before January 25, 2017.

Powered by Capital Market - Live News

Biocon drops on profit booking after hitting record high
Jan 10,2017

Shares of Biocon had jumped 8.26% in three sessions to settle at Rs 1,013 yesterday, 9 January 2017, from a close of Rs 935.65 on 4 January 2017.

Meanwhile, the S&P BSE Sensex was up 156.03 points or 0.58% at 26,882.06.

More than usual volumes were witnessed on the counter. On the BSE, 1.01 lakh shares were traded in the counter so far as against average daily volume of 75,444 shares in the past one quarter. The stock had hit a high of Rs 1,026 so far during the day, which is also a record high for the stock. The stock had hit a low of Rs 992.50 so far during the day. The stock had hit a 52-week low of Rs 430.80 on 12 February 2016.

The stock had outperformed the market over the past one month till 9 January 2017, gaining 7.39% compared with the Sensexs 0.08% fall. The scrip had also outperformed the market in past one quarter, rising 7.32% as against the Sensexs 4.76% fall.

The large-cap company has equity capital of Rs 100 crore. Face value per share is Rs 5.

Biocon reported consolidated net profit of Rs 146.70 crore in Q2 September 2016 as compared with net loss of Rs 10.60 crore in Q2 September 2015. The consolidated net sales rose 19.9% to Rs 932.10 crore in Q2 September 2016 over Q2 September 2015. The company will announce its Q3 results on 24 January 2017.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News

Centrum Capital spurts after bulk deal
Jan 10,2017

Meanwhile, the S&P BSE Sensex was up 151.23 points, or 0.57%, to 26,877.78

Bulk deal boosted volume on the scrip. On the BSE, 31.12 lakh shares were traded on the counter so far as against the average daily volumes of 6.27 lakh shares in the past one quarter. The stock hit a high of Rs 36.60 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 28.10 so far during the day. The stock hit a 52-week low of Rs 9.75 on 5 April 2016.

The stock had outperformed the market over the past 30 days till 9 January 2017, rising 8.6% compared with Sensexs 0.08% fall. The scrip had also outperformed the market in past one quarter, gaining 6.72% as against Sensexs 4.83% decline.

The small-cap financial services firm has an equity capital of Rs 41.60 crore. Face value per share is Re 1.

Centrum Capitals net profit rose 34% to Rs 3.35 crore on 31.54% growth in total income to Rs 25.36 crore in Q2 September 2016 over Q2 September 2015.

Centrum Capital is a Sebi registered category I merchant banker. It has expertise across equity & debt spectrum with capabilities in equity capital markets, M&A advisory, corporate finance & advisory, primary & secondary debt placement, project finance and corporate debt restructuring. Its retail arm provides integrated solutions for private wealth management, portfolio management, stock broking and foreign exchange.

Powered by Capital Market - Live News

Indias fuel product sales rise 4.4% in December 2016
Jan 10,2017

Indias fuel product consumption or sales increased 4.4% to 16.53 mt in December 2016 over a year ago. Petcoke sales increased 28.8% to 1.94 mt, while LPG sales moved up 8.2% to 1.94 mt and petrol 7.8% to 1.96 mt. Consumption of fuel oil also gained 14.2% to 0.60 mt, ATF 12.6% to 0.62 mt, and diesel 1.0% to 6.55 mt. Further, the consumption of lubes/greases increased 14.6% to 0.30 mt, and light diesel oil 10.1% to 0.04 mt. However, the consumption of bitumen declined 2.0% to 0.56 mt, others 4.8% to 0.55 mt, naphtha 5.5% to 1.08 mt, and kerosene 30.5% to 0.40 mt in December 2016.

Consumption or sales of fuel product increased 9.0% to 146.43 mt in April-December 2016 over April-December 2015. Sales of petcoke increased 42.4%, diesel 3.8%, petrol 11.2%, and LPG 11.1%. Consumption of fuel oil also moved up 17.1%, ATF 11.6%, bitumen 6.1% and lubes/greases 9.4%. Further, the consumption of naphtha inched up 1.4%, others 1.3% and light diesel oil 17.4%, but declined for kerosene 17.4% in April-December 2016.

Powered by Capital Market - Live News

Granules India gains on bargain hunting
Jan 10,2017

The announcement was made after market hours on Friday, 6 January 2017.

Meanwhile, the BSE Sensex was up 157.70 points, or 0.59%, to 26,884.25.

On the BSE, so far 3.51 lakh shares were traded in the counter, compared with average daily volumes of 1.69 lakh shares in the past one quarter. The stock had hit a high of Rs 105.80 and a low of Rs 102 so far during the day.

The stock hit a 52-week high of Rs 151.15 on 14 July 2016. The stock hit a 52-week low of Rs 91.45 on 9 November 2016. The stock had underperformed the market over the past 30 days till 9 January 2016, falling 9.92% compared with the 0.08% fall in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 15.84% as against Sensexs 4.83% decline.

The small-cap company has equity capital of Rs 22.12 crore. Face value per share is Re 1.

Shares of Granules India fell 9.84% to settle at Rs 101.20 yesterday, 9 January 2017, after the company announced that Infarmed, the Portuguese drug regulator, had conducted a renewal inspection on the companys facility located at Gagillapur, Telangana. In this respect, the company has received the inspection report from Infarmed with eleven observations. The Gagillapur facility manufactures Pharmaceuticals Formulation Intermediates (PFIs) and Finished Dosages (FDs).

The company has initiated necessary steps to address the observations of the inspection agency and will submit its response with a corrective and preventive action plan within the stipulated time, Granules India said. The company will also be requesting the Infarmed for re-inspection of the Gagillapur facility at the earliest. The company is committed to comply with all the required regulatory requirements and follow the best practices of the industry. The company acknowledges the observations as areas of continuous improvements, it added.

Granules Indias consolidated net profit rose 26.5% to Rs 40.82 crore on 3.08% growth in net sales to Rs 363.57 crore in Q2 September 2016 over Q2 September 2015.

Granules India is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. It manufactures active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs).

Powered by Capital Market - Live News

Bhel edges higher after winning order
Jan 10,2017

The announcement was made during market hours today, 10 January 2017.

Meanwhile, the BSE Sensex was up 158.69 points, or 0.59%, to 26,885.24.

On the BSE, 2.75 lakh shares were traded in the counter so far, compared with average daily volumes of 6.13 lakh shares in the past one quarter. The stock had hit a high of Rs 129.30 and a low of Rs 127.75 so far during the day. The stock had hit a 52-week high of Rs 162.80 on 8 September 2016. The stock had hit a 52-week low of Rs 90.40 on 29 February 2016.

The stock had underperformed the market over the past one month till 9 January 2017, falling 1.12% compared with the Sensexs 0.08% fall. The scrip had also underperformed the market in past one quarter, dropping 5.83% as against the Sensexs 4.76% fall.

The large-cap company has equity capital of Rs 489.52 crore. Face value per share is Rs 2.

Bharat Heavy Electricals (Bhel) said that it has bagged an order from PowerGrid Corporation of India for the augmentation of three extra voltage substations in Karnataka on turnkey basis valued at Rs 96 crore.

The augmentation of substation facilities is linked with the transmission system being set up for evacuation of solar power. The augmentation shall play a key role for transfer of renewable energy power from ultra mega solar power park of 2,000 megawatts capacity, phase II to be set up at Tumkur, Pavgada district on 10,000 acres of land.

The substations are slated to be commissioned in 18 months.

Bhel reported net profit of Rs 109 crore in Q2 September 2016 compared with net loss of Rs 180.78 crore in Q2 September 2015. Net sales rose 12.1% to Rs 6550.77 crore in Q2 September 2016 over Q2 September 2015.

State-run Bhel is an integrated power plant equipment manufacturer and an engineering and manufacturing company engaged in the design, engineering, manufacture, construction, testing, commissioning and servicing of a wide range of products and services for core sectors of the economy, viz. power, transmission, industry, transportation (railways), renewable energy, oil & gas, water and defence with over 180 products offerings.

The Government of India currently holds 63.06% stake in Bhel (as per the shareholding pattern as on 30 September 2016).

Powered by Capital Market - Live News

HDFC Bank gains after bulk deal
Jan 10,2017

Meanwhile, the S&P BSE Sensex was up 158.87 points or 0.59% at 26,885.42

Bulk deal boosted volume on the scrip. On the BSE, 5.33 lakh shares were traded on the counter so far as against the average daily volumes of 1.24 lakh shares in the past one quarter. The stock had hit a high of Rs 1,214 and a low of Rs 1,1996 so far during the day.

The stock had hit a 52-week high of Rs 1,318.20 on 23 September 2016. The stock had hit a 52-week low of Rs 928.80 on 29 February 2016. The stock had underperformed the market over the past 30 days till 9 January 2017, falling 0.27% compared with Sensexs 0.08% fall. The scrip had also underperformed the market in past one quarter, sliding 6.97% as against Sensexs 4.83% decline.

The large-cap bank has equity capital of Rs 511.07 crore. Face value per share is Rs 2.

HDFC Banks net profit rose 20.41% to Rs 3455.33 crore on 15.27% growth in total income to Rs 19970.89 crore in Q2 September 2016 over Q2 September 2015.

HDFC Bank is one of the leading private sector banks in India. As of 30 September 2016, the banks distribution network was at 4,548 branches and 12,016 ATMs across 2,596 cities/towns.

Powered by Capital Market - Live News